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Introduction: Asset based approaches to dementia research and measurement 
emphasise the need to also assess the strengths and capabilities that people with 
dementia retain, rather than assessing only losses or deficits. The CASP-19 proposes 
wellbeing as the satisfaction of four ‘needs’ (control, autonomy, self-realisation and 
pleasure). The CASP-19 may reflect the asses-based approach and has been validated 
in over 20 countries. The aim of this study was to evaluate the CASP-19’s 
psychometric properties in older adults with dementia. Methods: An observational 
study was conducted at five NHS trusts across England. Participants were asked to 
either complete the CASP-19 by interview or self-report, alongside four other 
measures to assess psychometric properties. Results: Internal consistency overall was 
good (α=.856) but the autonomy subscale fell below the acceptable. The CASP-19 
was significantly correlated in the expected direction with measures of quality of life 
(r= .707), depression (r= -.707) and additional measures. It also remained moderately 
stable over a one-week period but factor analyses indicated a 12-item measure may be 
more robust. Conclusions: Despite some variations, the CASP-19 appears to have 
adequate psychometric properties for older adults with dementia and can be used in 
future research and practice.  
 





Whilst quality of life is now widely accepted as a central outcome for older adults 
with dementia, there are growing concerns that it may focus unduly on health (Smith, 
et al., 2005) without proper consideration of positive psychology principles.  
 
The Control, Autonomy, Self-realisation and Pleasure (CASP-19) outcome measure 
builds on humanist psychology (Maslow, 1968), to emphasise wellbeing as the 
satisfaction of the four domains in its title. In this way, it assesses positive dimensions 
of ageing, which also helps to consider the increasing numbers of older adults who 
aim to pursue active and healthy lifestyles and many working beyond traditional 
retirement age (Institute for Economic Affairs, 2013).  
 
Since its inception, the CASP-19 has been used successfully in older adults with a 
range of chronic conditions including insomnia (Abell, Shipley, Ferrie, Kivimäki, & 
Kumari, 2016), urinary incontinence (Adamczuk, et al., 2015), and those with a 
physical disability (Connolly, Garvey, & McKee, 2017). Furthermore, the CASP-19 
has been used in over 20 countries and has been cross-culturally validated in places as 
diverse as Brazil (Lima, et al., 2014), Ethiopia (Hamren, Chungkham, & Hyde, 2015) 
and Spain (Pérez-Rojo, Martín, Noriega, & López, 2017). 
 
More recently, there has been increased recognition of the role of positive psychology 
for people with dementia including a study on hope in early stage dementia 
(Wolverson, Clarke, & Moniz-Cook, 2010). A systematic review on positive outcome 
measures identified the CASP-19 as a well-developed, asset based measure that could 
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be of use for people with dementia (Stoner, Orrell, & Spector, 2015), although little is 
known of its psychometric properties for this population. 
 
The aim of this study was to conduct and in-depth psychometric analysis for the 
CASP-19 in a sample of people with dementia to assess whether it is suitable for use 




Data for the current was collected as part of a larger, observational study on positive 
psychology measures at five NHS trusts across England. The study consisted of one 
baseline assessment and one re-test assessment within a one-week period on a 
subsample of participants. Participants either completed the assessments by interview 
or by self-report, depending on their preference.  
 
Participants 
Participants were primarily recruited through the Join Dementia Research (JDR) 
register, memory clinics, existing support groups and from previous research. The 
JDR is a joint initiative between the National Institute for Health Research (NIHR), 
Alzheimer Scotland, Alzheimer’s Research UK and the Alzheimer’s Society that 
enables people with dementia to sign up to a website to view and participate in 
research across the UK. Research assistants within each NHS trust identified 
individuals who were potentially eligible for inclusion if they had a formal diagnosis 
of dementia according to DSM-IV-TR criteria (American Psychiatric Association, 





Research assistants and clinical support officers were responsible for identifying 
potential participants within their own NHS trust. Eligible participants were contacted 
to ascertain interest in the study and to establish capacity to give consent, via an 
informal capacity assessment. Informal capacity assessments were conducted in 
accordance to established guidelines (The British Psychological Society, 2010; 
Department of Health, 2005). All research staff were Good Clinical Practice (GCP) 
certified and had been trained in the Mental Capacity Act (2005). All participants 
were provided with a full information sheet, an abbreviated and accessible 
information sheet and a consent form prior to data collection. Following consent 
procedures, participants were asked their preference for manner of completion. 
Participants were informed that the booklet could be sent to their address by post or 
email with a freepost return envelope, or that a research assistant could visit them at a 
place and time of their convenience to assist them with completion.  
 
Measures 
Participants were asked to provide demographic and clinical information consisting of 
age, sex, ethnicity, sub-type of dementia diagnosis, diagnosis date, co-morbid major 
physical or mental health conditions and current medication.  
 
The Control, Autonomy, Self-realisation and Pleasure Scale (CASP-19; Hyde, 
Wiggins, Higgs, & Blane, 2003) 
The CASP-19 was developed in a sample of 286 people aged 65 – 75 years and is 
measured on a four-point Likert scale (0- never, 3 often). Possible scores range from 0 
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– 57 (mean 42.2), with higher scores reflect higher levels of wellbeing. Internal 
consistency across the subscales is acceptable (control: α = .59; autonomy: α = .65; 
pleasure: α = .74; self-realisation: α = .77) and factor analyses provided evidence for a 
second order, latent quality of life factor.  
 
The Quality of Life in Alzheimer’s Disease (QoL-AD; Logsdon, Gibbons, McCurry, & 
Teri, 1999). 
The QoL-AD is a brief 13-item measure on a 4-point Likert scale, with scores ranging 
from 13 to 52. Higher scores indicate a better quality of life across domains of 
physical health, energy, mood, living situation, memory, family, marriage, friends, 
chores, fun, money, self and life as a whole. It has an acceptable reported level of 
internal consistency (0.77-0.84) and has demonstrated convergent validity with other 
quality of life and health related measures (Wolak-Thierry, et al., 2015). It was 
designed to be self-report and the scale can be completed even for those with more 
severe dementia (Thorgrimsen, et al., 2003). 
 
The Geriatric Depression Scale Short Form (GDS-15; Yesavage, Brink, Rose, & 
Adey, 1983) 
The GDS-15 is a 15-item measure with yes and no questions and designed to be self-
administered, although questions may be read out if required. A score of 10 or higher 
indicates depression with a sensitivity/ specificity ratio of 84%/ 95% (Yesavage, 
Brink, Rose, & Adey, 1983). The GDS-15 has been validated for people with 
dementia (Lesher & Berryhill, 1994) and is sensitive to change in older adults 




The Engagement and Independence in Dementia Questionnaire (EID-Q; Stoner, 
Orrell, Long, Csipke, & Spector, 2017) 
The EID-Q assesses the degree to which a person with dementia feels independent 
and is engaged socially with those around them. It is measured on a five-point Likert 
scale (0- not true at all, 4- true nearly all the time) and was developed in a sample of 
older adults with dementia. The EID-Q (Stoner, 2017) has excellent internal 
consistency (α=.91) and established correlations with the QoL-AD (r = .68) and the 
GDS-15 (r = -.74).  
 
The Positive Psychology Outcome Measure (PPOM; Stoner, Orrell, Long, Csipke, & 
Spector, 2017) 
The PPOM assesses hope and resilience for people with dementia and consists of an 
adapted version of the Herth Hope Index (Herth, 1992) and a resilience scale 
developed in a qualitative study of older adults with dementia. It is measured on a 
five-point Likert scale (0- not true at all, 4- true nearly all the time), has excellent 
internal consistency (α= .94) and established convergent validity with quality of life 
and depression (Stoner, 2017).  
 
Analysis 
Previous studies of the CASP-19 have suggested dealing with missing data by mean 
imputation at the 10% level (Kim, et al., 2015). Therefore, if a case had two or less 
instances of missing data, the mean of remaining items was imputed within the 
current study. Following this, multiple imputation (Rubin, 1987) was applied at a 
measure level using 20 imputations as ‘possible’ alternatives. Floor and ceiling effects 
were examined using visual inspections of histograms. If less than 15% of 
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respondents achieved the highest or lowest possible sores, ceiling and floor effects 
were not considered significant (Terwee, et al., 2007). Stability of the measures was 
assessed using intraclass correlation coefficient (ICC) between baseline and re-test. 
The CASP-19 was also assessed for internal consistency using a Cronbach alpha 
analysis at a subscale and measure level. 
 
To assess the convergent validity of the CASP-19 a Pearson’s r correlation was 
conducted between the CASP-19 and PPOM, EID-Q and GDS-15. It was a 
hypothesised that a positive correlation would be observed between the CASP-19 and 
the PPOM and EID-Q and a negative correlation would be observed between the 
CASP-19 and the GDS-15. Concurrent validity of the CASP-19 was established 
through an additional Pearson’s r correlation analysis of the relationship between the 
measure and the Quality of Life in Alzheimer’s Disease (QoL-AD). As both are 
proposed to measure quality of life, a positive correlation was hypothesised. 
 
To further evidence the content validity of the CASP-19, an exploratory factor 
analysis (EFA) and confirmatory factor analysis (CFA) was undertaken. Consistent 
with the original study, it was hypothesised that one second order ‘quality of life’ 
latent factor would emerge. To accomplish this, data was randomly halved and 
imported into MPlus and an EFA was run. Factors were then extracted using Kaiser’s 
criterion (Kaiser, 1960). Following this, the remaining random half of the data was 
imported into MPlus and the factor structure identified within the EFA was applied as 
confirmatory within the CFA. To test the fit of this factor structure, a number of fit 
indices were used including chi-squared statistics, comparative fit index (CFI), 
standardised room mean square residuals (SRMR) and root mean square error of 
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approximation (RMSEA). Following completion of the CFA, all data was integrated 
and the CFA was performed again to ensure the measurement model proposed was a 
good fit for all the data. Finally, models were compared with other established factor 




Participants consisted of 129 (57.3%) men and 96 (42.7%) women (n=225) with an 
average age of 77.1 (SD = 9.4). Demographic and clinical information can be found in 
Tables 1 and 2.  
 
[Insert Table 1 around here] 
 
Clinically, a large proportion had diagnosed with Alzheimer’s disease or dementia of 
mixed aetiology. Sixteen participants were not aware as to their specific sub-type 
diagnosis. Reasons for non-disclosure were variable with some participants indicating 
that they had not been informed as to the specific type, could not remember the sub-
type and information being unavailable at respective research sites (Table 2).  
 
[Insert Table 2 around here] 
 
To ensure that the subsample of participants who consented to be retested were 
representative of the sample in full, a series of independent samples t-tests were 
conducted for each of the demographic variables. None were significant, indicating 
the subsample was representative of the sample in full.  
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Floor and Ceiling Effects. 
Inspection of a histogram suggested that the CASP-19 followed a relatively normal 
distribution, with a very slight negative skew. The possible range of the CASP-19 was 
0 - 57 and the observed range was 15 - 57. Mean scores were 40.57 with a standard 
deviation of 9.08 and did not differ according to whether participants completed the 
study by self-report or by interview. No participants scored zero, whilst only two 
participants achieved the highest possible score of 57, indicating floor and ceiling 
effects were not significant (Figure 1). 
 
[Insert Figure 1 here] 
 
Internal Consistency 
The internal consistency of the CASP-19 was α=.856, which was considered 
adequate. The control subscale alpha was α= .645, the autonomy subscale was 
α=.505, the pleasure subscale was α=.718 and the self-realisation subscale had an 
internal consistency of α=.781. The subscale alphas were comparable to those 
originally reported for the CASP-19 (control: α= 0.59, autonomy: α= 0.65, pleasure: 
α= 0.74 and self-realisation: α= 0.77), with the exception of the autonomy subscale. 
However, items six and nine within this subscale were identified as only very 
marginally improving the consistency of the measure if removed (‘family 
responsibilities prevent me from doing what I want to do’: α=.859 and ‘shortage of 





Using a subsample of 48 participants, the CASP-19 showed good consistency within a 
one-week period (ICC=.859; 95%CI = .760 - .919) The control subscale demonstrated 
moderate consistency (ICC= .682; 95%CI = .495 - .809) as did the autonomy subscale 
(ICC= .703; 95%CI= .524 - .822). The pleasure subscale also demonstrated moderate 
consistency, although this was lower than both the autonomy and control subscales 
(ICC= .616; 95%CI= .401– 767). Self-realisation scores between baseline and retest 
were again moderately stable (ICC=.74; 95%CI = .578 - .846). 
 
Convergent and concurrent validity 
All Pearson’s r correlations were significant and within the expected direction, 
indicating convergent validity of the CASP-19 with the GDS-15 (r = -.707), EID-Q (r 
= .75) and PPOM (r = .73). The QoL-AD was also significantly correlated with the 
CASP-19 (r = 707), indicating concurrent validity (Table 3). An independent samples 
t-test indicated that participants who scored 10 or above on the GDS-15, and therefore 
are more likely to have significant depressive symptoms, were more likely to score 
lower on the CASP-19 (M= 26.58), than those who scored below 5 on the GDS-15, 
indicating little or no depressive symptomology (M= 43.91; t (175) = 10.498, p 
<.001).  
 
[Insert Table 3 around here] 
 
Factor Structure 
An EFA indicated the potential presence of six factors, with eigenvalues all above one 
(5.046, 2.056, 1.709, 1.148, 1.072, 1.045). However, an examination of item loadings 
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indicated the presence of four factors, consistent with that originally reported by the 
measure authors. Using a second order confirmatory factor analysis, consistent with 
the original study, fit indices were inadequate (Table 4) but all subscales significantly 
loaded onto the latent factor (control = 1.00, autonomy = 1.042, pleasure = 0.846 and 
self-realisation = 1.102). Item loadings for each subscale ranged from a low of .376 
for item six and a high of 1.264 for item eight.  
 
However, model fit here was not adequate and, therefore, other factor solutions were 
examined. Other authors (Vanhoutte, 2012; Wiggins et al., 2008) have proposed a 
shortened CASP-12, omitting item 3 from the control subscale, item 6 and 8 from the 
autonomy subscale, 13 and 14 from the pleasure subscale and items 16 and 17 from 
the self-realisation subscale. Two versions of this model were tested using a CFA, the 
first keeping the control and autonomy subscales separate and the second combing 
these two subscales (Table 4).  
 
[Insert Table 4 around here] 
 
Model fit here was much improved and marginally better for retaining all four 
subscales in a second order solution. However, when the internal consistency analysis 
was re-run using the 12-item solution, the internal consistency of the autonomy 
subscale was =.34. Combing the control and autonomy subscale led to an alpha of 
.65. Therefore, the model in which these subscales was combined was accepted as 
superior. Standardised factor loadings for the three subscales are presented in Figure 2 





Whilst item 9 had a lower factor loading it, removing it from the model caused all fit 
indices to worsen (CFI= .938, RMSEA= .059, SRMR= .057).  
 
[Insert Figure 2 around here].  
 
Discussion 
The evidence from this study indicates that the CASP-19 maintains adequate 
psychometric properties when used with people with dementia. Assessments of 
convergent and concurrent validity indicated a statistically significant relationship 
between the CASP-19, depression and quality of life as measured by the GDS-15 and 
QoL-AD respectively. However, analysis of the CASP-19 within the EFA stage, 
indicated the underlying latent factor reported by Hyde, Wiggins, Higgs and Blane 
(2003) was not adequate in a dementia population. Whilst all 19 items significantly 
loaded onto their respective factor, some fit indices fell below or above standard 
guidelines. As such, other factor solutions as reported by Vanhoutte (2012) and 
Wiggins et al., (2008) were examined and found to be more robust, suggesting this fit 
may be preferred for certain studies.  
 
Implications 
Results here indicate that the CASP-19 is a suitable positive psychology measure for 
people with dementia. The statistically significant correlation between the CASP-19, 
the QoL-AD and GDS-15 indicates that domains within the CASP-19 have important 
implications for both quality of life and depression for this population. All 
correlations were above r = .40 and, whilst harder to define, can be considered 
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clinically significant (Dunn, 2000; Evans, 1996). In particular, the independent 
samples t-test indicated that those who were more likely to have significant 
depressive symptomology scored on average 17 points lower on the CASP-19.  
 
Both quality of life and depression are well established as valuable outcomes and 
measures of these concepts are systematically included in a number of psychosocial 
research programmes (e.g. Orrell, et al., 2017; Wenborn et al., 2016; Whitaker, et al., 
2014). Based on evidence here, it is reasonable to suggest that positive concepts, such 
as those measured by the CASP-19 may be very closely related to these well 
etablished outcomes and further work is needed to explore whether it is possible to act 
on quality of life and depression vicariously, by intervening upon positive concepts.   
 
Much of the qualitative literature suggests that dementia impacts, often negatively, 
upon every aspect of a person’s life (e.g. Aminzadeh, Byszewski, Molnar, & Eisner, 
2007; Robinson, Clare, & Evans, 2005). However, average scores on the CASP-19 
here were largely similar to that of an older adult population (Hyde, Wiggins, Higgs 
& Blane, 2003). This suggests that positive concepts may be ingrained in identity or 
selfhood, and as such, largely unaffected by dementia (Caddell & Clare, 2010). 
 
Future research 
Psychometric properties reported here were adequate for people with dementia. 
Therefore, the measure should be considered appropriate for people with dementia, 
who retain capacity, and can be used in future research. The current study underlies 
the need for researchers to consider the psychometric implications of adopting 
measures for populations that they were not originally intended for. Content validity 
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is often established within one specific population and there is the need to consider 
whether this remains stable across participant groups.  
 
An important aspect of psychometric testing is that of responsiveness or, more 
simply, whether a measure can detect change as a result of an intervention. Whilst this 
could not be established here, the CASP-19 has been adopted for use in the Promoting 
Independence in Dementia (PRIDE) research programme in which a social 
intervention aimed at improving independence and wellbeing for people with 
dementia is being evaluated. Within the randomised controlled trial of this 
intervention, an analysis of responsiveness will be conducted to ensure that the 
CASP-19 is an adequate tool to measure change in this population.  
 
Methodological problems 
Obtaining demographic information could sometimes be challenging. Most 
commonly, participants were aware that they had ‘memory problems’ but were unable 
to recall whether they had been given a formal diagnosis or what this diagnosis was. 
Whilst this information was largely available for those who took part via the JDR, 
information for participants from other avenues was more difficult to obtain and could 
only be accomplished, with permission, through carer involvement or by accessing 
healthcare records. However, on a few occasions, this information could not be 
obtained and this is recognised as a limitation of the current work.  
 
Informal feedback from a carer indicated a potential issue in that a carer assisted a 
person with dementia to complete the measures in the guise of a conversation. This 
was not standard procedure for participants, due to potential bias, who were informed 
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they could either complete the study independently or with the assistance of a trained 
researcher. Future studies may wish to address this by using explicit instructions 
detailing completion procedures.  
 
Limitations 
Participants here were predominantly White-British, with Black, Asian and Minority 
Ethnic (BAME) groups accounting for only eight participants. Consequently, 
psychometric properties reported here are primarily for White-British older adults 
with dementia and, as such, inferences cannot be drawn as to the cross-cultural 
validity of the CASP-19 for older adults with dementia.  
 
The sample here primarily consisted of older adults with dementia. Whilst the 
inclusion criteria were purposively wide, participants under the age of 65 only 
accounted for 10.9% of the sample. It is likely that experiences of domains measured 
by the CASP-19 may differ for younger people with dementia who are often still in 
employment, have significant financial commitments and have dependent children or 
parents to care for (Roach, Keady, Bee & Hope, 2008). Future researchers may wish 
to conduct purposeful sampling to ensure younger people with dementia are 
represented within research. In relation to this, researchers may wish to consider more 
extensive testing of the CASP-19 within a larger and more varied sample.  
 
Conclusion 
Psychometric testing indicated adequate psychometric properties of the CASP-19 in a 
sample of people with dementia. Expected correlations were observed between 
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quality of life and depression. Of note, the factor structure of the CASP-12 appeared 
to be more robust than the CASP-19 suggesting it may be preferred for future studies.  
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Table 1 Participant demographics 













Age M (SD) Range 77.1 (9.4) 50-99 76.63 (10.2) 59-99 
Marital status n (%) 
   Single 
   Married 
   Widowed 















Ethnicity n (%) 
   White (British) 
   White (other) 






















Table 2 Participant clinical information 
 Total Sample 
(n = 225)  
Subsample 
(n =48) 
Dementia diagnosis n (%) 
   Alzheimer’s disease 
   Vascular dementia 
   Dementia of mixed aetiology 
   Parkinson’s related dementia 
Other 

















Time since diagnosis n (%) 
   <1 year 
   1- 3 years 
   3>  years 














Acetylcholinesterase inhibitor n (%) 
   None 
   Donepezil 
   Other 
    
Other major mental or physical health 
problem n (%) 
   None 






















Other psychotropic medication n (%) 
   None 












Table 3 Convergent and concurrent validity of the CASP-19 
 Control Autonomy Self-realisation Pleasure CASP-19 
GDS-15 -.614 -.537  -.646 -.571 -.707 
EID-Q .592 .525 .638 .501 .750 
PPOM .552 .444 .689 .571 .730 
QoL-AD .594 .560 .655 .441 .707 
All significant to p<.01 level.  
 
Table 4 Model fit indices for the CASP-19 and CASP-12 
 CFI RMSEA SRMR 
CASP 19: Four Subscales .812 .081 .073 
CASP 12: Four Subscales .947 .055 .045 












Figure 2 Standardised Factor Loadings for the CASP-12  
 
